Hepatitis A Vaccine (Human Diploid Cell), Inactivated - Healive®

Launched in 2002


lChina's only WHO prequalified hepatitis A vaccine


lAn inactivated hepatitis A vaccine. It is the most widely used hepatitis A vaccine in China, and has the most comprehensive clinical research study results


lEstablishes sustained protection for over 30 years after full-course immunization, based on output of statistical modeling


lExported to a dozen countries in Southeast Asia, Central and South America, the Middle East, and North Africa


lFollowing Healive®, Sinovac launched the first hepatitis A & B combined vaccine in China in 2005 to simultaneously prevent diseases caused by hepatitis A  B viruses.


Related news
year:
--ALL--
  • --ALL--
Load More
© SINOVAC